Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 3
1950 1
1951 1
1952 1
1954 1
1955 3
1957 2
1958 3
1960 1
1964 2
1965 2
1966 1
1968 3
1969 8
1970 2
1972 2
1973 5
1974 8
1975 6
1976 4
1977 4
1978 4
1979 2
1980 3
1981 5
1982 7
1983 8
1984 8
1985 15
1986 19
1987 10
1988 20
1989 18
1990 18
1991 28
1992 37
1993 47
1994 44
1995 65
1996 55
1997 70
1998 59
1999 69
2000 59
2001 51
2002 67
2003 96
2004 72
2005 120
2006 122
2007 123
2008 121
2009 148
2010 202
2011 248
2012 245
2013 240
2014 252
2015 296
2016 253
2017 311
2018 327
2019 401
2020 458
2021 508
2022 673
2023 668
2024 768
2025 982
2026 762

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,372 results

Results by year

Filters applied: . Clear all
Page 1
Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group; Lee TC, Barina LA, Walls G, Goodman AL, Yahav D, Cheng MP, Bonten M, Bowen AC, Boyles T, Daneman N, Ekkelenkamp MB, Ghanem-Zoubi N, Hensgens MPM, Jager NGL, Kaasch AJ, Kouijzer IJE, Lewis RJ, Lumley T, Lye DC, McDonald EG, McKew G, McLean ARD, McMullan BJ, McQuilten ZK, Morpeth SC, Paterson DL, Roberts JA, Robinson JO, Saito H, Scarborough M, Ten Oever J, Turner RM, Tverring J, van Hal SJ, Webb SA, Whiteway LM, Arias CA, Henderson A, Heriot GS, Snelling TL, Afra K, Ali SS, Amit S, Anagnostou NA, Archuleta S, Aston SJ, Athan E, Baharav N, Bai AD, Barber BE, Baskaran A, Berkeley MMA, Best EJ, Bhilave NR, Bloomfield MG, Bond KA, Bostock J, Botheras CL, Boyd MA, Bradshaw SME, Briggs EJ, Britton PN, Campbell AJ, Carr BZ, Chancellor JA, Chen K, Cheong EY, Chew KL, Chia PY, Chomba R, Chong BSW, Clews CJN, Cohen JM, Commons RJ, Cutfield T, Daley P, Daniel DS, Davies J, De P, Denholm JT, Di Virgilio M, Dishon-Benattar Y, Dotel R, Duan EH, Easom N, Eliakim-Raz N, England MM, Fahmy M, Findlater AR, Flanagan KL, Foo EZJ, Foo H, Forster DP, Fralick M, Frazer JL, Gador-Whyte AP, Garnham K, German GJ, Ghosh N, Gisolf EH, Giulier… See abstract for full author list ➔ Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group, et al. Among authors: lin rj. N Engl J Med. 2026 Jun 18;394(23):2329-2339. doi: 10.1056/NEJMoa2506905. N Engl J Med. 2026. PMID: 42308484 Free PMC article. Clinical Trial.
Reply to Letter.
Lin RZ, Tavella R, Shakib S, Beltrame JF. Lin RZ, et al. Cardiology. 2026 Jul 3:1-2. doi: 10.1159/000553412. Online ahead of print. Cardiology. 2026. PMID: 42397774 Free PMC article. No abstract available.
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.
Peng Z, Liu T, Wang H, Wang J, Liu H, Ye F, Li E, Zhang J, Liu B, Lin R, Zhou A, Liu Z, Xu H, Wang Q, Niu Z, Yuan Y, Qin Y, Qu X, Bai Y, Liu N, Liu H, Bai C, Pan Y, Wang S, Wu T, Pan Q, Zhong D, Lu H, Wang J, Wang Z, Deng T, Gou H, Huang X, Fu S, Lu P, Yu J, Hong M, Xu Q, Wang L, Ren Y, Fan S, Shen L; Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma study group. Peng Z, et al. Among authors: lin r. Nat Med. 2026 Aug;32(8):2888-2897. doi: 10.1038/s41591-026-04459-7. Epub 2026 Jun 1. Nat Med. 2026. PMID: 42225990 Clinical Trial.
Preclinical characterization and phase I results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumors.
Ruan DY, Lin SY, Huang JJ, Li YH, Li N, Qu XJ, Du XB, Yin YM, Yuan ZY, Shi YX, Xu F, An X, Hong RX, Xia W, Xue C, Bi XW, Jiang KK, Zheng QF, Zhang YQ, Peng JJ, Liu ZY, Xiong HH, Suo AL, Lin RB, Zhang S, Tang SN, Yu Y, Li X, Wang X, Tian X, Lv P, Shen C, Lou LG, Wang L, Zhang ZP, Xu TJ, Chen TX, Wang SS, Xu RH. Ruan DY, et al. Among authors: lin rb. Ann Oncol. 2026 Sep;37(9):1253-1265. doi: 10.1016/j.annonc.2026.05.003. Epub 2026 May 15. Ann Oncol. 2026. PMID: 42142622 Free article. Clinical Trial.
Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.
Lee PC, Cortellini A, Stefanini B, Yoo C, Chon HJ, Cheon J, Kudo M, Nishida N, Scheiner B, Pinter M, Lombardi P, Fulgenzi CAM, D'Alessio A, Brunetti L, Torkpour A, Valenzi E, Crowley F, Marron TU, Hsu WF, Celsa C, Cabibbo G, Cammà C, Galle PR, Vivaldi C, Masi G, Sharma R, Lin RP, Lin CY, Wietharn B, Saeed A, Tovoli F, Piscaglia F, Dalbeni A, Auriemma A, Sacerdoti D, Parisi A, Manfredi GF, Dondo A, Rimassa L, Pirisi M, Schönlein M, von Felden J, Singal AG, Parkih ND, Andanamala H, Ulahannan S, Roehlen N, Thimme R, Huang YH, Pinato DJ. Lee PC, et al. Among authors: lin rp. Eur J Cancer. 2026 Jun 3;240:116749. doi: 10.1016/j.ejca.2026.116749. Epub 2026 Apr 16. Eur J Cancer. 2026. PMID: 42030777 Free article.
8,372 results